Aging, Physical Activity, and Cardiac Function metabolism. [18] [19] [20] [21] [22] [23] However, limited evidence is available on the effect of objectively evaluated daily physical activity (as distinct from exercise training) on the age-related structural and functional changes in the heart, and particularly cardiac performance and metabolism. To date, only 1 study has reported an association between habitual physical activity, evaluated by a questionnaire, and left ventricular (LV) remodeling. 23 The lack of data describing the relationship between everyday physical activity, as opposed to structured exercise, and cardiovascular function with increasing age prevents evidence-based guidance on whether physical activity could be beneficial in attenuating the age-related decline in cardiovascular function. In light of this, the present study reports cardiac function, performance, and aerobic capacity in physically high-active and low-active young, middle-aged, and older women without cardiovascular disease. We hypothesized that a high level of daily physical activity, that is, >12 500 steps/d, 24 would attenuate age-related changes in cardiac function, performance, and aerobic capacity.
Methods

Subjects
Because of a significant difference in age-associated changes in cardiac morphology and function between men and women, 5, [25] [26] [27] [28] we designed the present study to define the effect of daily physical activity on the age-related changes on cardiac function, structure, metabolism, and performance in women.
Sixty-three healthy women were recruited from the Newcastle upon Tyne area (United Kingdom) into 3 groups: young (aged, 20-30 years; n=21), middle-age (aged, 40-50 years; n=22), and older (aged, 65-81 years; n=20) women. Subjects were included into the study if their objectively evaluated average daily physical activity level fell into a low active, that is, <7500 steps/d group or a high-active group, that is, >12 500 steps/d, as previously suggested. 24 Only subjects with normal glucose tolerance and lipid profile, body mass index <30 kg/m 2 , normal resting blood pressure and ECG, and able to undertake a maximal graded cardiopulmonary exercise stress test were included. Subjects were excluded if they (1) had any prior history of cardiovascular or chronic pulmonary disease, diabetes mellitus, or were using medication known to affect cardiovascular function, current or previous smoking, or exercise-limiting orthopedic impairment; (2) performed regular exercise (≥2× a week) during the previous 3 years or had been professional or semiprofessional athletes; (3) performed an average daily number of steps between 7500 and 12 500 steps/d. All subjects signed an informed consent form and the study was approved by the National Health Service Sunderland Research Ethics Committee.
Physical Activity and Body Composition Measurement
Physical activity was assessed objectively using a validated portable multisensor array (Sensewear Pro 3 , Bodymedia Inc, PA). 29 The monitor was worn for 7 days and was only removed for bathing. Self-reported physical activity was assessed using the International Physical Activity Questionnaire. 30 Body composition was measured using air displacement plethysmography (BodPod, Life Measurement Inc, CA).
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Exercise Testing With Noninvasive Central Hemodynamic Measurements
All subjects performed a maximal graded cardiopulmonary exercise test using an electromagnetically controlled semirecumbent bicycle ergometer (Corival, Lode, Groningen, The Netherlands) with online gas exchange measurements (Metalyzer 3B, Cortex, Leipzig, Germany) and noninvasive central hemodymamics by a bioreactance method (NICOM, Cheetah Medical, Deleware), as previously described. 32 Peak oxygen consumption was defined as the average oxygen uptake during the last minute of exercise. The difference in arterial-venous oxygen content (mLO 2 /100 mL of blood) was calculated from measured oxygen consumption and cardiac output at peak exercise. Cardiac power output, a direct measure of cardiac pumping capability, 33, 34 was calculated as the product of cardiac output and mean arterial blood pressure.
26
Cardiac Magnetic Resonance Examinations
Cine Imaging
A 3T Philips Intera and a 6-channel cardiac coil (both Philips, Best, NL) were used with the subjects in a supine position and ECG gating. Balanced steady-state-free precession images were obtained in the short axis view during breath holding, covering the left ventricle (field of view, 350 mm; repetition time/echo time, 3.7/1.9 ms; turbo factor, 17; flip angle, 40°; thickness, 8 mm; 0-mm gap; 14 slices; 25 phases; resolution 1.37 mm; temporal duration, ≈40 ms per phase). Image analysis was performed using the cardiac analysis package of the ViewForum workstation (Philips, Best, NL). Manual tracing of the epicardial and endocardial borders was performed on the short axis slices at end-systole and end-diastole. Details of our algorithm for contour selection and our methods for subsequently calculating LV mass, systolic and diastolic parameters have been described elsewhere. 35 The ratio of the LV mass to the end-diastolic volume was calculated as this parameter is a measure of concentric remodeling.
Cardiac Tagging
Tagged short axis images were obtained at the same session. Cardiac tagging works by applying radiofrequency pulses to cancel MR signal from the myocardium in diastole in a rectangular grid pattern and tracking the deformation of these tags through the rest of the cardiac cycle. 36 A turbo-field echo sequence with acceleration factor 9 was used (repetition time/echo time/flip angle/number of signal averages, 4.9/3.1/10°/1; SENSE factor 2; field of view, 350×350 mm; voxel size, 1.37×1.37 mm; orthogonal Complementary Spatial Modulation of Magnetization grid 36 with tag spacing of 7 mm). Short axis slices of 10-mm thickness were prescribed as previously detailed. 37 The Cardiac Image Modelling package (University of Auckland) was used to analyze the tagging data by aligning a mesh on the tags between the endo-and epicardial contours. Circumferential strain was calculated throughout the cardiac cycle and is quoted for both the whole myocardial wall and the endocardial third of the wall thickness at midventricle. The cardiac torsion was calculated for each cardiac phase. 37 In the healthy heart, torsion occurs such that there is homogeneity of fiber shortening across the myocardial wall 6 and indicates the dominance of epicardial fibers over endocardial fibers as a consequence of greater radius. The relationship between torsion and strain can be approximated by a ratio of the peak torsion and the peak circumferential strain in the endocardial third of the myocardium, the torsion:shortening ratio. 6, 38 This ratio is constant among healthy subjects of the same age and increases with healthy aging. 6, 9 Both torsion and torsion:shortening ratio are measures of epicardial-endocardial interactions.
Longitudinal shortening was determined from cine-MRI in the 4-chamber view by determining the perpendicular distance from the plane of the mitral valve to the apex in systole and diastole. The myocardial wall thickness at systole and diastole was determined at the same level as the cardiac tagging.
Cardiac Spectroscopy
Cardiac high-energy phosphate metabolism was assessed using 31 P MRS to record the ratio of myocardial phosphocreatine:ATP (PCr/ ATP). Data were collected using the same 3T Intera Achieva scanner (Philips, Best, NL) with a 10-cm diameter 31 P surface coil (Pulseteq, UK) for transmission/reception of signal. Full experimental details are provided in the Methods in the Data Supplement. Sample spectra using this technique have been published previously. 
Statistical Analysis
All statistical analysis was performed using SPSS version 19.0 (SPSS Inc, Chicago, IL). Before statistical analysis, data were checked for Aging, Physical Activity, and Cardiac Function univariate and multivariate outliers using standard Z-distribution cutoffs and Mahalanobis distance tests. Normality of distribution was assessed using a Kolmogorov-Smirnov test, which indicated that primary outcomes were normally distributed. Two-way ANOVA was used to determine the main effects of age and physical activity and the interaction between the age and physical activity on primary outcomes including measures of cardiac structure, function, metabolism, and performance. Pearson coefficient of correlation was used to assess the relationship between variables. As LV structure and function are subject to the influence of body dimensions, the data were scaled to body surface area. Statistical significance was indicated if P<0.05. All data are presented as mean±SD unless otherwise indicated.
Results
Subjects Characteristics
From 129 women who contacted the research team to take part in the study, 63 met the study inclusion criteria: 21 young (10 low, 11 high active; average age, 26±3 years), 22 middle-age (10 low, 12 high active; average age, 45±3 years), and 20 older (10 low, 10 high active; average age, 72±5 years) women. The average physical activity levels for high-active groups were young-age 14 807±1624, middle-age 15 398±1910, and older-age 14 442±1524 steps/d. The average physical activity levels for lowactive groups were young-age 6321±985, middle-age 6086±1035, and older-age 5996±1002 steps/d. Only 5 subjects (2 older, 2 middle-age, and 1 younger) demonstrated sedentary behavior (<5000 steps/d). The intensity of activity level ranged from low to moderate (≤6 metabolic equivalent units), and this was expected as no participant was taking part in any regular exercise.
Age was associated with reduced lean body mass (r=−0.32; P=0.04), increased blood triglycerides (r=0.45; P<0.01), total cholesterol (r=0.62; P<0.01), low-density lipoprotein cholesterol (r=0.50; P<0.01), and 2-hour glucose (r=0.49; P<0.01). The effect of age on body composition and blood profile measures is indicated in the Data Supplement (Table 1) . At any age, high-active women demonstrated lower body weight, body surface area, fat body mass, body mass index, triglycerides, low-density lipoprotein cholesterol, insulin, and 2-hour glucose (P<0.05, Table 1 ).
Cardiac Structure
Age was associated with a decrease in end-systolic (r=−0.36; P<0.01) and end-diastolic volumes (r=−0.27; P=0.04) and an increase in wall thicknesses (r=0.53; P<0.01) and LV mass:volume ratio (ie, eccentricity ratio) increased with age (r=0.36; P<0.01; Figure 1A ). No significant correlation was found between age and LV mass index (P=0.98). The effect of age on measures of cardiac structure is indicated in the Data Supplement (Table 2 ). However, there was a significant effect of physical activity on LV mass index in all age groups with high-active subjects demonstrating greater mass index (P<0.05; Figure 2A ). Physical activity had no effect on eccentricity ratio in any of the age groups ( Figure 2B ), whereas end-systolic and diastolic volume indices were between 20% (P<0.05) and 46% (P<0.01) greater in young-and middle-age high-active than in low-active women, but not in the older group (P=0.33).
Cardiac Function and Metabolism
In contrast with cardiac systolic function (ie, stroke volume index, cardiac index, and LV ejection fraction) that was preserved with age, diastolic function (ie, ratio of early-tolate ventricular filling and early filling percentage) progressively declined with advancing age (r=−0.72; Figure 1B and r=−0.41; P<0.01). The effect of age on measures of systolic and diastolic cardiac function is presented in the Data Supplement ( Table 2 ). The young-and middle-age high-active group demonstrated higher stroke volume index than the low-active group (P<0.05), whereas no effect of physical activity on stroke volume index was observed in older group (P=0.40; Table 2 ). There was a significant effect of physical activity level on early-to-late ventricular filling ratio in the youngand middle-age groups, but not in older women (P<0.05; Figure 2C ).
Peak LV torsion and torsion:shortening ratio significantly increased with advancing age (P<0.05) and a significant effect of physical activity was observed in young-age (P<0.05), but not in middle-age and older women, respectively ( Figure 2D ; Table 2 ). Longitudinal shortening progressively declined with age (P<0.05) and was not affected by physical activity in any age group.
Age was significantly associated with cardiac high-energy phosphate (r=−0.27; P<0.05; Figure 1C ). The PCr/ATP ratio was significantly reduced in the older-compared with the middle-and young-age groups (young, 1.9±0.3; middle, 2.1±0.3; and older, 1.7±0.2; P<0.01) and was significantly affected by physical activity level (P<0.05). High-active young and older women demonstrated 21% and 23% higher PCr/ATP ratio than low-active women ( Figure 3A) . Interestingly, high-active older women had PCr/ATP ratio similar to that of young but low-active women (P=0.56). Although middle-aged women tended to have higher values of PCr/ATP than younger women for matched activity level, this effect did not reach statistical significance.
Cardiac Performance
Age was associated with decline in cardiac performance and pumping capability as assessed by peak exercise cardiac power output (r=−0.37; P<0.01; Figure 1D ), maximal flow generating capacity of the heart, that is, cardiac output (r=−0.48; P<0.01), and oxygen consumption (r=−0.54; P<0.01). Advanced age was also associated with an increase in maximal pressure generating capacity of the heart, that is, mean arterial blood pressure (r=0.51; P<0.01) and systematic vascular resistance (r=0.61; P<0.01). The effect of age on measures of cardiac performance is presented in the Data Supplement (Table 3) . At any age, high-active women demonstrated a greater level of relative peak oxygen consumption than low-active women (P<0.01). Nonsignificant difference was found in exercise capacity (oxygen consumption/kg and work rate/kg) between older active and young-and middleage low-active women (Table 3 ; Figure 3B ). However, physical activity had no effect on peak exercise cardiac power output ( Figure 3C ) but maximal cardiac index was significantly higher in young-and middle-age high-active than lowactive women (P<0.05; Figure 3D ), because of higher stroke volume. In contrast, there was no effect of physical activity on peak exercise cardiac index (P=0.40) and stroke volume index (P=0.31) between older high-and low-active women (Table 3) . Advancing age was also associated with a decline Aging, Physical Activity, and Cardiac Function in the ability of muscles to extract oxygen, the arterial-venous O 2 difference, and a significant effect of physical activity was found in all 3 age groups with statistically significant differences (P<0.05) ranging between 13% and 19% between highand low-active women (Table 3) .
Discussion
This is the first study to examine the effect of objectively evaluated daily physical activity on age-related changes in cardiac structure, function, metabolism, and performance. The major finding suggests that a high level of daily physical Figure 1 . Relationship between age and measures of cardiac structure, that is, eccentricity ratio (A), diastolic function, that is, early-to-late diastolic filling rate (B), metabolism, that is, phosphocreatine:ATP ratio (C), and pumping capability, that is, peak cardiac power output (D). Aging, Physical Activity, and Cardiac Function activity preserves cardiac metabolism and exercise capacity with aging but has a limited effect on age-related changes in cardiac structure, diastolic function, pumping capability, and LV wall motion in women. This finding is important as it demonstrates that increased physical activity in older women has no significant effect on age-related myocardial structural and With aging there was an increase in mass:volume ratio suggesting concentric remodeling, as previously reported. 5 In contrast with men, women preserve their full complement of cardiac myocytes during the lifespan. 25 Concentric remodeling in aging heart is related to coupling of ventricular and vascular stiffening process that occurs during a life course. 22, 39 Decline in diastolic function with aging is reported elsewhere. 4, 9, 22, 26, 27 This is because of intrastructural and cellular changes including an increase in myocardial collagen deposition, proliferation of the matrix, nonenzymatic cross-linking associated with advanced glycation end products rendering collagen molecules stiffer, and calcium activation from the preceding systole. 1, 3 Furthermore, our data show that sensitive measures of the LV wall motion and contraction such as peak torsion and torsion:shortening ratio were higher in older women. This indicates a potential subendocardial dysfunction, which is further associated with reduction in longitudinal shortening observed with physiological aging and hypertrophic cardiomyopathy. 6, 7, 9 Previous studies also demonstrated a decline in cardiac high-energy phosphate (PCr/ATP ratio) in older individuals. 9, 10 This may be because of multiple reasons, such as altered creatine content or the activity of creatine kinase which we cannot determine from these data. However, it may be pertinent that the old low-active and high-active groups have plasma triglyceride levels that are 62% and 69% greater than those of the young-and middle-aged groups, respectively: previous studies of normotensive subjects with significantly raised triglyceride levels because of obesity, 40 nonalcoholic fatty liver disease, 41 or type 2 diabetes mellitus 42 had significantly reduced PCr/ATP ratios compared with their controls groups, including type 2 diabetes mellitus controls with lower triglyceride concentrations. Furthermore, a significant reduction in plasma triglyceride concentration in obesity because of weight loss was associated with a significant increase in PCr/ATP ratio. 43 Under these circumstances, fatty acids may be preferentially used over glucose as a cardiac substrate, decreasing metabolic efficiency as more oxygen is needed per ATP molecule generated. Where triglyceride levels were comparable between controls and nonalcoholic fatty liver disease, no difference in PCr/ATP is found. 44 Looking at those subjects with triglyceride above the normal range (>1.7 mmol/L, n=7, all older subjects), the mean PCr/ATP ratio is 1.74±0.16, whereas those in the normal range have mean PCr/ATP ratio 2.12±0.49 (P=0.015). Interestingly, the middle-aged women had numerically higher but not significant PCr/ATP ratios than younger women, in contrast to our previous data. 9 It should be noted that there is a wide variation in this group (although within normative values) and authors suggest that the variance may be because of a combination of population sampling 45 heterogeneous activity levels and triglyceride levels, as opposed to a specific age-related mechanism.
Peak exercise cardiac power output, as a direct measure of overall cardiac function and pumping capability 33 declined with aging because of ≈20% reduction in cardiac output. These findings are in agreement with those of Fleg et al, 27 but contrary to those of Goldspink et al 26 who argued that the female heart demonstrates resilience to aging with no reduction in Figure 3 . Measures of cardiac metabolism and performance according to age and physical activity. Cardiac high-energy phosphate (A), maximal aerobic capacity (B), peak cardiac pumping capability (C), and peak cardiac index (D). *P<0.05, high vs low active; **P<0.01, high vs low active; and †P<0.01 old vs young and middle age. Aging, Physical Activity, and Cardiac Function peak exercise cardiac power output. Maximal aerobic capacity was lower in older women 11, 21 because of a decline in both cardiac output and arterial-venous oxygen difference.
Although increased activity level was associated with improved cardiovascular risk factors, its impact on cardiac structure and function was not straightforward. First, from the perspective of cardiac structure, although high-active youngand middle-age women demonstrate significantly greater LV volumes and mass index, older women had lower end-systolic volume and greater LV mass index in comparison with lowactive older women. Interestingly, physical activity had no significant effect on eccentricity ratio in any age group. One previous study examined the association between intentional exercise of moderate to vigorous intensity and LV remodeling. 23 Results revealed that higher physical activity levels were associated with greater LV mass.
Young-and middle-aged high-active women had better diastolic function compared with their low-active comparison groups. No significant difference was found in the older-age group. Gates et al 22 found that regular aerobic-endurance exercise does not modulate age-associated changes in diastolic function in men. In contrast, Forman et al 46 showed that earlyto-late filling ratio was higher in well-trained men and women. The present data suggest that diastolic function declines with age, irrespective of daily physical activity level, supporting the hypothesis that the impairment of diastolic function is intrinsic to normative aging and may not be reversed with increased physical activity or exercise. 47 Torsion:shortening ratio was not significantly different between high-and low-active middle-age and older women. This suggests that physical activity had no effect on age-related changes in subendocardial dysfunction, which is thought to be because of a subendocardial fibrosis associated with aging. 6 In contrast, older high-active women demonstrate a significantly higher level of cardiac high-energy phosphate metabolism than low-active women. Moreover, PCr/ATP ratio values found in our older low-active women were similar to some subjects with dilated cardiomyopathy. 8 Although low values for PCr/ATP ratios in individuals without heart disease have been recorded before, 9, 10, 45 this study is the first to demonstrate difference because of activity level. Previous reports have shown that men undergoing long-term endurance training showed a higher level of cardiac metabolism 20 and that sex has no effect on age-related cardiac metabolic change. 10 It seems that not only intentional exercise but also a high level of daily physical activity might be considered to be beneficial for cardiac energetics in nontrained individuals.
Finally, from the view of cardiac performance, although youngand middle-aged high-active women demonstrate significantly higher peak exercise cardiac index than low-active women, no Aging, Physical Activity, and Cardiac Function such effect was observed in older women. Interestingly, peak exercise cardiac power output was not significantly different between the activity groups regardless of age, suggesting that daily physical activity has no effect on age-associated decline in maximal cardiac pumping capability. Aerobic capacity (peak oxygen consumption) and exercise performance (work rate), however, were markedly influenced by daily activity. One of the physiological mechanisms that may explain such a finding is that the anaerobic threshold point occurs significantly earlier in low-active than in those highly active women. As the rate of lactate acid production and accumulation exceeds its removal from the muscle, it is likely to cause an onset of fatigue and consequent earlier termination of the exercise test, resulting in a lower exercise performance (work rate) in inactive women. The observed higher fitness level in active women is important as it is associated with better quality of life and functional independence, 11, 18 making them capable of performing physical tasks that cannot be performed by their sedentary peers.
The present study is not without limitations. Only women were studied because of the significant differences in age-associated changes in cardiac morphology and function between men and women. It is not known whether these results extend to men, to people with cardiac diseases, or people with other comorbidities. All of the women taking part were white and it is not known whether these results are applicable to subjects from other ethnic backgrounds. The range of PCr/ATP ratios in this cohort was wider than our previously published work 9 but comparable with those from other cohorts acquiring cardiac spectroscopy in healthy controls with this technique. 48, 49 Although the overall sample size was large for a detailed physiological study, subject numbers were limited when stratified for age and physical activity level. Because of a large number of comparisons made for a relatively modest sample size, it is possible that in some cases type I error has been made.
In conclusion, the data reveal that aging is associated with cardiac concentric remodeling, a decline in diastolic function, cardiac metabolism, subendocardial dysfunction, and maximal performance. A physically active lifestyle preserves cardiac metabolism and aerobic capacity with aging but has limited effect on age-related changes in cardiac structure, diastolic function, LV wall motion, and pumping capability, particularly in older women.
CLINICAL PERSPECTIVE
Physical activity reduces all-cause and cardiovascular mortality in both women and men. Low active and sedentary individuals have significantly greater risk to develop cardiovascular disease than high-active individuals. Physical activity and cardiovascular function decline with age and little is known about the effect of daily physical activity on the age-related structural and functional changes in the heart. The lack of data describing the relationship between everyday physical activity, as opposed to structured exercise, and cardiovascular function with increasing age prevents evidence-based guidance on whether physical activity could be beneficial in attenuating the age-related decline in cardiovascular function. In light of this, the present study reports cardiac function, performance, and aerobic capacity in physically high-active (>12 500 steps/d) and low-active (<7500 steps/d) young, middle-aged, and older women without cardiovascular disease. The major findings suggest that high level of daily physical activity preserves cardiac metabolism and exercise capacity with aging, but has limited effect on age-related changes in concentric remodeling, diastolic function, and cardiac performance.
